Carl Philip Lebel

age ~65

from Swampscott, MA

Get Report

Also known as:

Carl P Lebel
Carl L Lebel
Carl E Lebel
Ccarl P Lebel
Carl P Lebell
Carl P Bel
Carl Le Bel
Carl P Le-Bel
Carl Lobel

Phone and address:: 53 Tupelo Rd, Swampscott, MA 01907
3103176184

Connected to:

Carl Lebel Phones & Addresses

53 Tupelo Rd, Swampscott, MA 01907 • 3103176184
455 Massachusetts Ave APT 1, Boston, MA 02118
Roxbury, MA
23256 Mariposa De Oro St, Malibu, CA 90265 • 3103176184
11213 Bentcreek Rd, Moorpark, CA 93021 • 8055297372
North Andover, MA
Los Angeles, CA
Detroit, MI
Saline, MI

Work

Company:

Northeastern university, bouvé college of health sciences
Apr 2017 to Apr 2018
Position:

Entrepreneur in residence

Education

School / High School:

University of California, Irvine - College of Medicine
1989 to 1990

Skills

Biotechnology • Health Sciences

Industries

Biotechnology

Resumes

Chief Development Officer

view source

Location:

6275 Nancy Ridge Dr, San Diego, CA 92121

Industry:

Biotechnology

Work:

Northeastern University, Bouvé College of Health Sciences Apr 2017 - Apr 2018
Entrepreneur In Residence
Frequency Therapeutics Apr 2017 - Apr 2018
Chief Development Officer
Lebel Consulting Apr 2017 - Apr 2018
Founder
Otonomy, Inc Feb 2009 - Nov 2016
Chief Scientific Officer
Akesis Pharmaceuticals Jun 2008 - Jan 2009
President and Chief Executive Officer

Education:

University of California, Irvine - College of Medicine 1989 - 1990
Northeastern University 1984 - 1989
Doctorates, Doctor of Philosophy, Biomedical Science, Toxicology University of Detroit Mercy 1976 - 1980
Bachelors, Bachelor of Science, Chemistry

Skills:

Biotechnology
Health Sciences

Us Patents

Controlled Release Antimicrobial Compositions And Methods For The Treatment Of Otic Disorders
view source
US Patent:

8318817, Nov 27, 2012
Filed:

Jul 20, 2009
Appl. No.:

12/506127
Inventors:

Jay Lichter - Rancho Santa Fe CA, US
Carl Lebel - Malibu CA, US
Fabrice Piu - San Diego CA, US
Qiang Ye - San Diego CA, US
Luis A. Dellamary - San Marcos CA, US
Andrew M. Trammel - Olathe KS, US
Jeffrey P. Harris - La Jolla CA, US
Assignee:

Otonomy, Inc. - San Diego CA
The Regents of the University of California - Oakland CA
International Classification:

A01N 25/00
A61K 47/00
A61K 47/30
A61K 9/14
US Classification:

514772, 5147723, 424486, 424489
Abstract:

Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Controlled Release Cytotoxic Agent Compositions And Methods For The Treatment Of Otic Disorders
view source
US Patent:

8349353, Jan 8, 2013
Filed:

Jun 29, 2009
Appl. No.:

12/493611
Inventors:

Jay Lichter - Rancho Santa Fe CA, US
Andrew M. Trammel - Olathe KS, US
Jeffrey P. Harris - La Jolla CA, US
Carl Lebel - Malibu CA, US
Fabrice Piu - San Diego CA, US
Qiang Ye - San Diego CA, US
Luis A. Dellamary - San Marcos CA, US
Assignee:

Otonomy, Inc. - San Diego CA
The Regents of the University of California - Oakland CA
International Classification:

A61F 9/02
A61K 9/54
A61K 9/58
A61K 31/74
A61K 45/00
US Classification:

424437, 424 7808, 424 7831, 4242801, 424458, 424462
Abstract:

Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with cytotoxic agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Controlled Release Ion Channel Modulator Compositions And Methods For The Treatment Of Otic Disorders
view source
US Patent:

8399018, Mar 19, 2013
Filed:

Jul 21, 2009
Appl. No.:

12/506664
Inventors:

Jay Lichter - Rancho Santa Fe CA, US
Benedikt Vollrath - San Diego CA, US
Sergio G. Duron - San Diego CA, US
Carl Lebel - Malibu CA, US
Fabrice Piu - San Diego CA, US
Qiang Ye - San Diego CA, US
Luis A. Dellamary - San Marcos CA, US
Andrew M. Trammel - Olathe KS, US
Michael Christopher Scaife - Los Altos CA, US
Jeffrey P. Harris - La Jolla CA, US
Assignee:

Otonomy, Inc. - San Diego CA
The Regents of The University of California - Oakland CA
International Classification:

A61K 9/14
US Classification:

424484
Abstract:

Disclosed herein are compositions and methods for the treatment of otic disorders with ion channel modulators. In these methods, the ion channel modulator compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the ion channel modulator compositions and formulations onto the auris interna target areas, or via perfusion into the auris interna structures.

Controlled Release Auris Sensory Cell Modulator Compositions And Methods For The Treatment Of Otic Disorders
view source
US Patent:

8496957, Jul 30, 2013
Filed:

Jul 16, 2009
Appl. No.:

12/504553
Inventors:

Jay Lichter - Rancho Santa Fe CA, US
Benedikt Vollrath - San Diego CA, US
Sergio G. Duron - San Diego CA, US
Carl Lebel - Malibu CA, US
Fabrice Piu - San Diego CA, US
Qiang Ye - San Diego CA, US
Luis A. Dellamary - San Marcos CA, US
Andrew M. Trammel - Olathe KS, US
Michael Christopher Scaife - Los Altos CA, US
Jeffrey P. Harris - La Jolla CA, US
Assignee:

Otonomy, Inc - San Diego CA
The Regents of the University of California - Oakland CA
International Classification:

A61K 9/14
A61K 31/47
A61K 31/517
US Classification:

424437, 424489, 5142661, 514312, 514646
Abstract:

Disclosed herein are methods for the treatment of otic diseases or conditions with intratympanic compositions and formulations of multiparticulate auris sensory cell modulating agent administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Controlled Release Auris Sensory Cell Modulator Compositions And Methods For The Treatment Of Otic Disorders
view source
US Patent:

8575122, Nov 5, 2013
Filed:

Apr 26, 2010
Appl. No.:

12/767461
Inventors:

Jay Lichter - Rancho Santa Fe CA, US
Carl Lebel - Malibu CA, US
Fabrice Piu - San Diego CA, US
Andrew M. Trammel - Olathe KS, US
Assignee:

Otonomy, Inc. - San Diego CA
International Classification:

A61K 9/46
US Classification:

514 44R
Abstract:

Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with auris sensory cell modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Controlled Release Immunomodulator Compositions And Methods For The Treatment Of Otic Disorders
view source
US Patent:

8648119, Feb 11, 2014
Filed:

May 26, 2009
Appl. No.:

12/472034
Inventors:

Jay Lichter - Rancho Santa Fe CA, US
Andrew M. Trammel - Olathe KS, US
Fabrice Piu - San Diego CA, US
Qiang Ye - San Diego CA, US
Luis A. Dellamary - San Marcos CA, US
Carl Lebel - Malibu CA, US
Jeffrey P. Harris - La Jolla CA, US
Assignee:

Otonomy, Inc. - San Diego CA
The Regents of the University of California - Oakland CA
International Classification:

A61K 47/30
A61K 38/00
US Classification:

5147726, 5147727, 514 122
Abstract:

Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agent compositions and formulations administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Auris Formulations For Treating Otic Diseases And Conditions
view source
US Patent:

20090306225, Dec 10, 2009
Filed:

Apr 21, 2009
Appl. No.:

12/427663
Inventors:

Jay LICHTER - Rancho Santa Fe CA, US
Benedikt VOLLRATH - San Diego CA, US
Andrew M. TRAMMEL - Olathe KS, US
Sergio G. DURON - San Diego CA, US
Fabrice PIU - San Diego CA, US
Luis A. DELLAMARY - San Marcos CA, US
Qiang YE - San Diego CA, US
Carl LEBEL - Malibu CA, US
Michael Christopher SCAIFE - Los Altos CA, US
Jeffrey P. HARRIS - La Jolla CA, US
Assignee:

Otonomy, Inc. - San Diego CA
The Regents of the University of California - Oakland CA
International Classification:

A61K 47/30
A61P 27/16
US Classification:

5147721
Abstract:

Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.

Controlled-Release Cns Modulating Compositions And Methods For The Treatment Of Otic Disorders
view source
US Patent:

20090325938, Dec 31, 2009
Filed:

Jun 29, 2009
Appl. No.:

12/494156
Inventors:

Jay Lichter - Rancho Santa Fe CA, US
Benedikt Vollrath - San Diego CA, US
Sergio G. Duron - San Diego CA, US
Carl Lebel - Malibu CA, US
Fabrice PIU - San Diego CA, US
Qiang Ye - San Diego CA, US
Luis A. Dellamary - San Marcos CA, US
Andrew M. Trammel - Olathe KS, US
Michael Christopher Scaife - Los Altos CA, US
Jeffrey P. Harris - La Jolla CA, US
Assignee:

OTONOMY, INC. - San Diego CA
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:

A61K 31/5517
A61K 31/5513
A61K 31/164
US Classification:

514220, 514221, 514626
Abstract:

Disclosed herein are compositions and methods for the treatment of otic disorders with CNS modulating agent compositions and compositions administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and compositions onto or via perfusion into the targeted auris structure(s).